Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia
Chimeric antigen receptor T cells (CAR T cells) have resulted in dramatic treatment responses for patients with hematologic malignancies, resulting in improved survival for patients with intractable disease. The first patient treated with CD19 directed CAR T cell therapy had chronic lymphocytic leuk...
Main Authors: | Benjamin M. Heyman, Dimitrios Tzachanis, Thomas J. Kipps |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/7/1715 |
Similar Items
-
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia
by: Christina Amatya, et al.
Published: (2024-03-01) -
Therapeutic advancement of chronic lymphocytic leukemia
by: Lu Kang, et al.
Published: (2012-09-01) -
Infections in patients with chronic lymphocytic leukemia
by: Mariana Guarana, et al.
Published: (2023-07-01) -
Meningeal involvement in chronic lymphocytic leukemia
by: S. N. Menshakova, et al.
Published: (2022-11-01) -
Novel Agents in Chronic Lymphocytic Leukemia: New Combination Therapies and Strategies to Overcome Resistance
by: Moritz Fürstenau, et al.
Published: (2021-03-01)